Hypertension is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Newton Laboratories, Inc.. The primary component is Micrurus Corallinus Venom; Epinephrine; Arsenic Triiodide; Gold; Barium Carbonate; Bryonia Alba Root; Selenicereus Grandiflorus Stem; Chelidonium Majus; Cinchona Officinalis Bark; Crotalus Horridus Horridus Venom; Digitalis; Nitroglycerin; Potassium Carbonate; Potassium Iodide; Lachesis Muta Venom; Naja Naja Venom; Strychnos Nux-vomica Seed; Veratrum Album Root; Vipera Berus Venom; Viscum Album Fruiting Top; Ruta Graveolens Flowering Top; Valerian.
Product ID | 55714-4424_f886f05e-a0ff-fbe4-8213-f31d1fd99f45 |
NDC | 55714-4424 |
Product Type | Human Prescription Drug |
Proprietary Name | Hypertension |
Generic Name | Elaps Corallinus, Adrenalinum, Arsenicum Iodatum , Aur. Met., Baryta Carb., Bryonia, Cactus, Chelidonium Majus, Cinchona, Crotalus Horridus, Digitalis, Glonoinum, Kali Carb., Kali Iod ., Lachesis , Naja , Nux Vom., Veratrum Alb., Vipera Berus, Viscum, Ruta, Valeriana |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2011-06-01 |
Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
Labeler Name | Newton Laboratories, Inc. |
Substance Name | MICRURUS CORALLINUS VENOM; EPINEPHRINE; ARSENIC TRIIODIDE; GOLD; BARIUM CARBONATE; BRYONIA ALBA ROOT; SELENICEREUS GRANDIFLORUS STEM; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; NITROGLYCERIN; POTASSIUM CARBONATE; POTASSIUM IODIDE; LACHESIS MUTA VENOM; NAJA NAJA VENOM; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT; VIPERA BERUS VENOM; VISCUM ALBUM FRUITING TOP; RUTA GRAVEOLENS FLOWERING TOP; VALERIAN |
Active Ingredient Strength | 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharm Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE],Nitrate Vasodilator [EPC],Nitrates [CS],Vasodilation [PE],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS],Seed Storage Proteins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2011-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-06-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-06-01 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
MICRURUS CORALLINUS VENOM | 30 [hp_X]/mL |
SPL SET ID: | b1619473-c1b2-6e35-07c2-cc7ab77a18d7 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
55714-4424 | Hypertension | Elaps corallinus, Adrenalinum, Arsenicum iodatum , Aur. met., Baryta carb., Bryonia, Cactus, Chelidonium majus, Cinchona, Crotalus horridus, Digitalis, Glonoinum, Kali carb., Kali iod ., Lachesis , Naja , Nux vom., Veratrum alb., Vipera berus, Viscum, Ruta, Valeriana |
55714-4425 | Hypertension | Elaps corallinus, Adrenalinum, Arsenicum iodatum , Aur. met., Baryta carb., Bryonia, Cactus, Chelidonium majus, Cinchona, Crotalus horridus, Digitalis, Glonoinum, Kali carb., Kali iod ., Lachesis , Naja , Nux vom., Veratrum alb., Vipera berus, Viscum, Ruta, Valeriana |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() HYPERTENSION 88782363 not registered Live/Pending |
Kunshan Hanbo Tengsheng E-commerce Technology Co., Ltd. 2020-02-03 |
![]() HYPERTENSION 74514444 not registered Dead/Abandoned |
Physicians World Communications Group 1994-04-20 |